https://www.pharmagrowthjournal.com/archives/year-2026.volume-3.issue-1 2026-01-23 weekly 0.6 https://www.pharmagrowthjournal.com/archives/year-2026.volume-3.issue-2 2026-03-17 weekly 0.6 https://www.pharmagrowthjournal.com/archives/year-2026.volume-3.issue-3 2026-05-07 weekly 0.6 https://www.pharmagrowthjournal.com/archives/year-2025.volume-2.issue-1 2025-09-17 weekly 0.6 https://www.pharmagrowthjournal.com/archives/year-2025.volume-2.issue-2 2025-09-17 weekly 0.6 https://www.pharmagrowthjournal.com/archives/year-2025.volume-2.issue-3 2025-06-20 weekly 0.6 https://www.pharmagrowthjournal.com/archives/year-2025.volume-2.issue-4 2025-08-13 weekly 0.6 https://www.pharmagrowthjournal.com/archives/year-2025.volume-2.issue-5 2025-10-21 weekly 0.6 https://www.pharmagrowthjournal.com/archives/year-2025.volume-2.issue-6 2025-12-10 weekly 0.6 https://www.pharmagrowthjournal.com/archives/year-2024.volume-1.issue-1 2024-10-11 weekly 0.6 https://www.pharmagrowthjournal.com/archives/year-2024.volume-1.issue-2 2024-10-11 weekly 0.6 https://www.pharmagrowthjournal.com/archives/year-2024.volume-1.issue-3 2024-10-11 weekly 0.6 https://www.pharmagrowthjournal.com/archives/year-2024.volume-1.issue-4 2024-10-12 weekly 0.6 https://www.pharmagrowthjournal.com/archives/year-2024.volume-1.issue-5 2024-10-12 weekly 0.6 https://www.pharmagrowthjournal.com/archives/year-2024.volume-1.issue-6 2025-03-19 weekly 0.6 https://www.pharmagrowthjournal.com/article/75/development-and-validation-of-a-derivative-uv-visible-spectrophotometric-method-for-the 2026-05-07 monthly 0.8 https://www.pharmagrowthjournal.com/article/74/slma-protein-master-coordinator-of-bacterial-chromosome-partitioning-and-cell-division-an-extensive 2026-03-17 monthly 0.8 https://www.pharmagrowthjournal.com/article/73/development-and-evaluation-of-buprenorphine-buccal-film-for-controlled-release 2026-01-23 monthly 0.8 https://www.pharmagrowthjournal.com/article/72/chemical-composition-and-biological-activities-of-citrus-nobilis-essential-oil-collected-in-dak-lak 2025-12-10 monthly 0.8 https://www.pharmagrowthjournal.com/article/71/ai-driven-nanopharmacology-intelligent-nano-systems-transforming-drug-discovery-and-therapeutic 2025-12-06 monthly 0.8 https://www.pharmagrowthjournal.com/article/70/prevalence-of-vitamin-d3-and-vitamin-b12-in-obese-women-and-their-correlation-with-bmi-severity 2025-11-19 monthly 0.8 https://www.pharmagrowthjournal.com/article/69/herbal-medicines-as-therapeutic-agents-against-heavy-metal-toxicity-mechanisms-and-perspectives 2025-11-08 monthly 0.8 https://www.pharmagrowthjournal.com/article/68/multiple-emulsions-for-sustainable-drug-delivery 2025-10-21 monthly 0.8 https://www.pharmagrowthjournal.com/article/67/chemical-composition-and-antibacterial-activity-of-litsea-cubeba-lour-pers-essential-oil 2025-10-21 monthly 0.8 https://www.pharmagrowthjournal.com/article/66/polyclonal-malaria-infections-and-drug-resistance-evolution-implications-for-treatment-strategies 2025-10-10 monthly 0.8 https://www.pharmagrowthjournal.com/article/65/cell-free-biotechnology-in-clinical-therapeutics-protein-synthesis-platforms-for-rapid-drug-and 2025-09-20 monthly 0.8 https://www.pharmagrowthjournal.com/article/64/advanced-erp-tools-benefits-challenges-for-materials-machines-resource-cost-management 2025-09-17 monthly 0.8 https://www.pharmagrowthjournal.com/article/63/fragile-supply-chain-structure-geographic-concentration-limited-domestic-capacity-in-the-united 2025-09-17 monthly 0.8 https://www.pharmagrowthjournal.com/article/62/edible-vaccines-and-the-chemical-engineering-of-plant-based-biopharmaceuticals-emerging-molecular 2025-09-06 monthly 0.8 https://www.pharmagrowthjournal.com/article/61/study-factors-affecting-the-content-of-essential-oil-of-vernonia-amygdalina-and-alphaglucosidase 2025-08-13 monthly 0.8 https://www.pharmagrowthjournal.com/article/60/development-and-validation-of-a-rp-hplc-method-for-the-analysis-of-darolutamide-in-bulk-and 2025-08-01 monthly 0.8 https://www.pharmagrowthjournal.com/article/59/analytical-rp-hplc-method-development-and-validation-for-the-estimation-of-lenvatinib-and-api-form 2025-07-29 monthly 0.8 https://www.pharmagrowthjournal.com/article/56/a-systematic-review-of-personalized-medicine-s-role-in-improving-cancer-therapy-and-outcomes 2025-06-20 monthly 0.8 https://www.pharmagrowthjournal.com/article/55/conceptual-review-of-biosimilar-adoption-in-clinical-practice-comparing-effectiveness-and 2025-06-20 monthly 0.8 https://www.pharmagrowthjournal.com/article/54/reviewing-pharmacovigilance-strategies-using-real-world-data-for-drug-safety-monitoring-and 2025-06-14 monthly 0.8 https://www.pharmagrowthjournal.com/article/53/evaluating-the-role-of-pharmacists-in-chronic-disease-management-a-review-of-patient-outcomes-and 2025-05-20 monthly 0.8 https://www.pharmagrowthjournal.com/article/52/antibacterial-and-antioxidant-activities-of-essential-oil-from-plectranthus-amboinicus-collected-in 2025-05-02 monthly 0.8 https://www.pharmagrowthjournal.com/article/51/evaluation-of-helicobacter-pylori-infections-effect-on-serum-ferritin-levels-a-clinical-perspective 2025-04-22 monthly 0.8 https://www.pharmagrowthjournal.com/article/50/inhibits-diabetes-from-plectranthus-amboinicus-lour 2025-04-15 monthly 0.8 https://www.pharmagrowthjournal.com/article/49/synthesis-eugenoxyacetic-acid-structure-and-some-exports 2025-04-14 monthly 0.8 https://www.pharmagrowthjournal.com/article/48/chemical-composition-and-biological-activities-of-rosemary-essential-oil-rosmarinus-oficinalis-l 2025-04-14 monthly 0.8 https://www.pharmagrowthjournal.com/article/47/the-in-vitro-anti-inflammatory-and-antioxidant-activitites-of-the-bark-extracts-from-castanea 2025-04-14 monthly 0.8 https://www.pharmagrowthjournal.com/article/46/maternal-mental-health-and-parenting-children-with-disabilities-a-systematic-review-of 2025-04-09 monthly 0.8 https://www.pharmagrowthjournal.com/article/45/ozone-therapy-in-fibromyalgia-a-comprehensive-review 2025-04-03 monthly 0.8 https://www.pharmagrowthjournal.com/article/42/preventive-health-programs-collaboration-between-healthcare-providers-and-public-health-agencies 2025-03-19 monthly 0.8 https://www.pharmagrowthjournal.com/article/41/enhancing-operational-efficiency-in-healthcare-the-role-of-advanced-data-analytics 2025-03-19 monthly 0.8 https://www.pharmagrowthjournal.com/article/40/bridging-mental-health-and-national-security-the-transformative-impact-of-psychiatric-nursing-on 2025-03-18 monthly 0.8 https://www.pharmagrowthjournal.com/article/38/telepsychiatry-and-digital-mental-health-interventions-the-future-of-psychiatric-nursing 2025-03-15 monthly 0.8 https://www.pharmagrowthjournal.com/article/37/leveraging-artificial-intelligence-to-alleviate-nurse-workload-and-improve-patient-care 2025-03-15 monthly 0.8 https://www.pharmagrowthjournal.com/article/36/the-medical-importance-of-sodium-and-potassium 2025-03-06 monthly 0.8 https://www.pharmagrowthjournal.com/article/35/the-effectiveness-of-herbal-medicines-in-modern-pharmaceutical-practices-a-systematic-review 2025-01-13 monthly 0.8 https://www.pharmagrowthjournal.com/article/34/exploring-the-role-of-pharmacogenomics-in-personalized-medicine-implications-for-drug-therapy 2025-01-13 monthly 0.8 https://www.pharmagrowthjournal.com/article/33/nanomedicine-in-targeted-cancer-therapy-current-trends-and-future-prospects 2025-01-13 monthly 0.8 https://www.pharmagrowthjournal.com/article/32/pharmacokinetic-and-pharmacodynamic-interactions-a-comprehensive-study-on-drug-drug-interactions 2025-01-13 monthly 0.8 https://www.pharmagrowthjournal.com/article/31/advancements-in-drug-repurposing-unveiling-new-therapeutic-potential-for-existing-drugs 2025-01-13 monthly 0.8 https://www.pharmagrowthjournal.com/article/30/outline-in-addition-judgment-from-pharmacosomes-tricky-accompanying-telmisartan 2024-12-13 monthly 0.8 https://www.pharmagrowthjournal.com/article/29/expression-incident-in-addition-description-from-ppis-pantoprazole-as-orodispersible-tablets 2024-12-13 monthly 0.8 https://www.pharmagrowthjournal.com/article/28/some-scrutinize-in-contact-pharmacological-endeavors-of-butea-monosperma 2024-12-13 monthly 0.8 https://www.pharmagrowthjournal.com/article/27/any-scrutinize-on-collide-of-polycystic-ovarian-disease-on-insane-well-being 2024-12-13 monthly 0.8 https://www.pharmagrowthjournal.com/article/26/uniformity-of-monetary-lavangathi-chooranams-a-approximate-examine 2024-12-13 monthly 0.8 https://www.pharmagrowthjournal.com/article/25/corporeal-and-haemato-biochemical-judgment-of-skeletally-inexperienced-dogs-accompanying-tibial 2024-10-12 monthly 0.8 https://www.pharmagrowthjournal.com/article/24/supra-cutaneous-plating-for-the-repair-of-tibial-shaft-fracture-in-cats 2024-10-12 monthly 0.8 https://www.pharmagrowthjournal.com/article/23/expression-of-often-wooden-moringa-oleifera-escape-leaf-powder-defended-cold-pressed-fruit 2024-10-12 monthly 0.8 https://www.pharmagrowthjournal.com/article/22/semantic-as-well-as-biometrical-examine-of-liver-from-pre-contrived-chabro-hen 2024-10-12 monthly 0.8 https://www.pharmagrowthjournal.com/article/21/physico-synthetic-reasoning-from-synthetic-manufacturing-discharge 2024-10-12 monthly 0.8 https://www.pharmagrowthjournal.com/article/20/gamma-fallout-persuaded-artificial-mutagenesis-in-mixture-beverage-red-pink-cv-deluge 2024-10-12 monthly 0.8 https://www.pharmagrowthjournal.com/article/19/antagonistic-instigative-action-of-tridax-procumbens-on-light-rodent-by-utilizing-plethysmography 2024-10-11 monthly 0.8 https://www.pharmagrowthjournal.com/article/18/expression-and-judgment-of-mucoadhesive-buccal-patches-of-diclofenac-sodium 2024-10-11 monthly 0.8 https://www.pharmagrowthjournal.com/article/17/establishment-signifying-plan-happening-and-confirmation-of-nitisinone-in-clean-form-in-advertised 2024-10-11 monthly 0.8 https://www.pharmagrowthjournal.com/article/16/investigates-the-effect-of-foreign-direct-investment-on-economic-growth-in-cameroon 2024-10-11 monthly 0.8 https://www.pharmagrowthjournal.com/article/15/a-new-examining-design-incident-and-confirmation-for-the-determinable-belief-of-antagonistic 2024-10-11 monthly 0.8 https://www.pharmagrowthjournal.com/article/14/expression-and-judgment-of-doxorubicin-liposomal-drug-transfer-arrangement 2024-10-11 monthly 0.8 https://www.pharmagrowthjournal.com/article/13/growth-and-description-of-chlorambucil-polymeric-nanoparticles 2024-10-11 monthly 0.8 https://www.pharmagrowthjournal.com/article/12/expression-and-judgment-of-olmesartan-midoxomiltopical-coagulate 2024-10-11 monthly 0.8 https://www.pharmagrowthjournal.com/article/11/examining-order-growth-and-confirmation-for-the-belief-of-revaprazan-all-inclusive-form-and 2024-10-11 monthly 0.8 https://www.pharmagrowthjournal.com/article/10/examining-procedure-incident-and-confirmation-for-the-belief-of-clomipramine-hcl-in-api-form-and 2024-10-11 monthly 0.8 https://www.pharmagrowthjournal.com/article/9/a-new-examining-pattern-happening-and-confirmation-for-the-belief-of-bedaquiline-by-reverse-point 2024-10-11 monthly 0.8 https://www.pharmagrowthjournal.com/article/8/expression-and-judgment-of-naproxen-opening-disappearing-tablets 2024-10-11 monthly 0.8 https://www.pharmagrowthjournal.com/article/7/phytochemical-study-and-judgment-of-antidiabetic-and-antioxidant-effectiveness-of-adansonii-monstera 2024-10-11 monthly 0.8 https://www.pharmagrowthjournal.com/article/6/1-2-dihydroquinoline-sulphonamides-synthesis-characterization-and-biological-evaluation 2024-10-11 monthly 0.8 https://www.pharmagrowthjournal.com/article/5/design-formulate-and-description-of-methylphenidate-reserved-release-tablets 2024-10-11 monthly 0.8 https://www.pharmagrowthjournal.com/article/4/happening-and-artificial-judgment-of-rizatriptan-oro-capable-of-disintegration-tablets 2024-10-10 monthly 0.8 https://www.pharmagrowthjournal.com/article/3/combination-and-description-of-benzothiazole-and-1-2-3-triazole-located-bisheterocycles-for 2024-10-10 monthly 0.8 https://www.pharmagrowthjournal.com/article/2/arrangement-incident-and-confirmation-of-antagonistic-malignancy-drug-erlotinib-in-advertised-drug 2024-10-10 monthly 0.8 https://www.pharmagrowthjournal.com/article/1/expression-and-judgment-of-salbutamol-sulphate-buccal-patches 2024-10-10 monthly 0.8